주식/증권
📉 부정적
관련 뉴스
Janux Therapeutics GAAP EPS of -$0.34 beats by $0.14, revenue of $9.29M beats by $2.87M
11/05/2026
Rlj outlines 2026 adjusted FFO per share guidance of $1.47-$1.51 as it targets 2 conversions per year
11/05/2026
Tectonic Therapeutic GAAP EPS of -$1.08 beats by $0.24
11/05/2026
Wells Fargo’s Top Investment Banker Sees ‘Now or Never’ Window for Dealmaking
11/05/2026